InvestSMART

Raptor Metals Ltd (ASX: RAP) - Announcements

Current share price for RAP : $0.025 0.001 (3.85%)+

ASX company news and announcements for Raptor Metals Ltd (RAP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Raptor Metals Ltd (RAP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Raptor Metals Ltd (RAP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Raptor Metals Ltd (RAP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$10 Investor Presentation 22 Apr 2020 9:47AM $0.155 $0.025 fallen by 83.87%
$10 Appendix 3G 7 Apr 2020 6:33PM $0.185 $0.025 fallen by 86.49%
$10 Initial Director's Interest Notice 6 Apr 2020 7:04PM $0.195 $0.025 fallen by 87.18%
$10 ResApp Appoints Dr Michael Stein as a Non-Executive Director 6 Apr 2020 9:02AM $0.185 $0.025 fallen by 86.49%
$10 ResApp Announces SleepCheck, a Sleep Apnoea Screening App 1 Apr 2020 9:32AM $0.195 $0.025 fallen by 87.18%
$10 Final Director's Interest Notice 31 Mar 2020 7:51PM $0.195 $0.025 fallen by 87.18%
$10 Coviu and ResApp Complete Initial ResAppDx-EU Integration 30 Mar 2020 10:01AM $0.140 $0.025 fallen by 82.14%
$10 Resignation of Non-Executive Director 30 Mar 2020 9:37AM $0.140 $0.025 fallen by 82.14%
$10 ResApp Builds European Market Presence 26 Mar 2020 9:25AM $0.130 $0.025 fallen by 80.77%
$10 ResAppDx-EU to be Deployed on Phenix Health Telehealth App 24 Mar 2020 9:44AM $0.069 $0.025 fallen by 63.77%
$10 Investor Conference Call 11 Mar 2020 4:33PM $0.084 $0.025 fallen by 70.24%
$10 Update on US FDA De Novo Classification Request 11 Mar 2020 9:54AM $0.170 $0.025 fallen by 85.29%
$10 Direct-to-Consumer Product Update 11 Mar 2020 9:54AM $0.170 $0.025 fallen by 85.29%
$10 Trading Halt 9 Mar 2020 9:53AM $0.170 $0.025 fallen by 85.29%
$10 Appendix 4D and Half Year Financial Report 28 Feb 2020 3:14PM $0.165 $0.025 fallen by 84.85%
$10 Section 708A Notice and Appendix 2A 27 Feb 2020 9:45AM $0.200 $0.025 fallen by 87.50%
$10 Proposed issue of Securities - RAP 21 Feb 2020 10:11AM $0.240 $0.025 fallen by 89.58%
$10 ResApp Completes $5 Million Capital Raising 21 Feb 2020 10:10AM $0.240 $0.025 fallen by 89.58%
$10 TGA Approval for Adult Respiratory Disease Diagnosis 20 Feb 2020 11:57AM $0.240 $0.025 fallen by 89.58%
$10 Trading Halt 19 Feb 2020 9:25AM $0.240 $0.025 fallen by 89.58%
$10 Proposed issue of Securities - RAP 18 Feb 2020 9:54AM $0.240 $0.025 fallen by 89.58%
$10 Functional Testing of Handheld and Wearable Devices Complete 18 Feb 2020 9:43AM $0.240 $0.025 fallen by 89.58%
$10 Quarterly Update and Appendix 4C 31 Jan 2020 9:34AM $0.255 $0.025 fallen by 90.20%
$10 Change of Director's Interest Notice x 4 20 Dec 2019 5:33PM $0.255 $0.025 fallen by 90.20%
$10 Appendix 3B 20 Dec 2019 5:25PM $0.255 $0.025 fallen by 90.20%

251 - 275 of 572 results

Page 11 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.